174 related articles for article (PubMed ID: 35090513)
1. Downregulation of NEDD4L by EGFR signaling promotes the development of lung adenocarcinoma.
Li G; Song Z; Wu C; Li X; Zhao L; Tong B; Guo Z; Sun M; Zhao J; Zhang H; Jia L; Li S; Wang L
J Transl Med; 2022 Jan; 20(1):47. PubMed ID: 35090513
[TBL] [Abstract][Full Text] [Related]
2. JAC4 Inhibits EGFR-Driven Lung Adenocarcinoma Growth and Metastasis through CTBP1-Mediated JWA/AMPK/NEDD4L/EGFR Axis.
Ding K; Jiang X; Wang Z; Zou L; Cui J; Li X; Shu C; Li A; Zhou J
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240137
[TBL] [Abstract][Full Text] [Related]
3. Down-regulated NEDD4L facilitates tumor progression through activating Notch signaling in lung adenocarcinoma.
Lin L; Wu X; Jiang Y; Deng C; Luo X; Han J; Hu J; Cao X
PeerJ; 2022; 10():e13402. PubMed ID: 35646490
[TBL] [Abstract][Full Text] [Related]
4. Nucleophosmin promotes lung adenocarcinoma cell proliferation, migration and invasion by activating the EGFR/MAPK signaling pathway.
Li M; Wu R; Zhu D; Wang L; Liu S; Wang R; Deng C; Zhang S; Chen M; Lu R; Zhu H; Mo M; Luo Z
Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37165929
[TBL] [Abstract][Full Text] [Related]
5. ALCAP2 inhibits lung adenocarcinoma cell proliferation, migration and invasion via the ubiquitination of β-catenin by upregulating the E3 ligase NEDD4L.
Zhang W; Zhang R; Zeng Y; Li Y; Chen Y; Zhou J; Zhang Y; Wang A; Zhu J; Liu Z; Yan Z; Huang JA
Cell Death Dis; 2021 Jul; 12(8):755. PubMed ID: 34330894
[TBL] [Abstract][Full Text] [Related]
6. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of HE4 suppresses tumor growth and invasiveness in lung adenocarcinoma through regulation of EGFR signaling.
Zhang Y; Yang W; Han X; Qiao Y; Wang H; Chen T; Li T; Ou WB
Oncol Res; 2024; 32(6):1119-1128. PubMed ID: 38827327
[TBL] [Abstract][Full Text] [Related]
8. CD73 (NT5E) Promotes the Proliferation and Metastasis of Lung Adenocarcinoma through the EGFR/AKT/mTOR Pathway.
Zhang H; Cao Y; Tang J; Wang R
Biomed Res Int; 2022; 2022():9944847. PubMed ID: 35813221
[TBL] [Abstract][Full Text] [Related]
9. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
[No Abstract] [Full Text] [Related]
10. Circular RNA CDR1-AS contributes to pemetrexed and cisplatin chemoresistance through EGFR/PI3K signaling pathway in lung adenocarcinoma.
Mao Y; Xu R
Biomed Pharmacother; 2020 Mar; 123():109771. PubMed ID: 31881486
[TBL] [Abstract][Full Text] [Related]
11. TIMELESS promotes the proliferation and migration of lung adenocarcinoma cells by activating EGFR through AMPK and SPHK1 regulation.
Yin H; Wang Z; Wang D; Nuer M; Han M; Ren P; Ma S; Lin C; Chen J; Xian H; Ai D; Li X; Ma S; Lin Z; Pan Y
Eur J Pharmacol; 2023 Sep; 955():175883. PubMed ID: 37433364
[TBL] [Abstract][Full Text] [Related]
12. The impact of PRDX4 and the EGFR mutation status on cellular proliferation in lung adenocarcinoma.
Mizutani K; Guo X; Shioya A; Zhang J; Zheng J; Kurose N; Ishibashi H; Motono N; Uramoto H; Yamada S
Int J Med Sci; 2019; 16(9):1199-1206. PubMed ID: 31588184
[No Abstract] [Full Text] [Related]
13. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.
Lu GS; Li M; Xu CX; Wang D
Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076
[TBL] [Abstract][Full Text] [Related]
14. PAR2 promotes tumor-associated angiogenesis in lung adenocarcinoma through activating EGFR pathway.
Li Y; Huang H; Chen X; Yu N; Ye X; Chen L; Huang Z
Tissue Cell; 2022 Dec; 79():101918. PubMed ID: 36148733
[TBL] [Abstract][Full Text] [Related]
15. GLUT1 promotes cell proliferation via binds and stabilizes phosphorylated EGFR in lung adenocarcinoma.
Zhou Z; Li Y; Chen S; Xie Z; Du Y; Liu Y; Shi Y; Lin X; Zeng X; Zhao H; Chen G
Cell Commun Signal; 2024 Jun; 22(1):303. PubMed ID: 38831321
[TBL] [Abstract][Full Text] [Related]
16. C1orf74 positively regulates the EGFR/AKT/mTORC1 signaling in lung adenocarcinoma cells.
Guo J; Li A; Guo R; He Q; Wu Y; Gou Y; Jin J; Huang G
PeerJ; 2022; 10():e13908. PubMed ID: 36032960
[TBL] [Abstract][Full Text] [Related]
17. The E3 ubiquitin ligase NEDD4 mediates cell migration signaling of EGFR in lung cancer cells.
Shao G; Wang R; Sun A; Wei J; Peng K; Dai Q; Yang W; Lin Q
Mol Cancer; 2018 Feb; 17(1):24. PubMed ID: 29455656
[TBL] [Abstract][Full Text] [Related]
18. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
Front Immunol; 2021; 12():724741. PubMed ID: 34335635
[TBL] [Abstract][Full Text] [Related]
19. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
[TBL] [Abstract][Full Text] [Related]
20. NEDD4L-induced ubiquitination mediating UBE2T degradation inhibits progression of lung adenocarcinoma via PI3K-AKT signaling.
Chen Y; Hong H; Wang Q; Li J; Zhang W; Chen T; Li P
Cancer Cell Int; 2021 Nov; 21(1):631. PubMed ID: 34838005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
